Navigation Links
Adult Circumcision Reduces Risk of HIV Transmission Without Reducing Sexual Pleasure
Date:4/27/2009

LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Two studies presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA) show that adult circumcision reduces the risk of contracting the human immunodeficiency virus (HIV) and the risk of coital injury -- without reducing pleasure or causing sexual dysfunction.

The first study, by researchers in Australia, shows that the inner foreskin has the largest concentration of Langerhans' cells, which are the initial cellular targets in the sexual transmission of HIV. After analyzing biopsy samples from 10 uncircumcised and 10 circumcised men, researchers found that the inner foreskin has a significantly higher density of Langerhans' cells than other areas of the foreskin. By removing the inner foreskin, circumcision removes the skin surface which is most susceptible to HIV infection, reducing not eliminating the risk of contracting HIV. No differences were found in epithelial or keratin thickness between the remnant foreskin, inner foreskin or shaft skin.

The second study, by researchers in Seattle, WA; Chicago, IL; Winnipeg, Canada; Research Triangle, NC; and Kisumu, Kenya, shows that circumcised men had a significantly lower risk for coital injuries (bleeding, scratches, cuts, abrasions or "getting sore") compared to uncircumcised men and that there was no difference in sexual function between circumcised and uncircumcised men. Researchers divided 2,784 patients from Kisumu, Kenya into two groups: a control group and a group to be circumcised within 30 days of randomization. Detailed evaluations were done at one, three, six, 12, 18 and 24 months after circumcision. Results show that there was no difference in sexual function between the two groups and that the circumcised group reported fewer coital injuries.

"These are important reports which support the concepts that circumcision does not interfere with sexual function and t
'/>"/>

SOURCE American Urological Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children
2. Heavy Marijuana Use May Damage Developing Brain in Teens, Young Adults
3. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
4. New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy
5. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
6. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
7. Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients
8. Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy
9. Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
10. Exercise Helps Prevent Age-Related Brain Changes in Older Adults
11. New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire-FirstCall/ -- American Scientific Resources...ed to announce that they have opened a regional ma...ai, China. ,, ASR has been able to secure a loc...he development and production of current and futur...ts to be distributed and sold globally. Currently...
(Date:11/25/2009)...wire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS...ted to discovering, developing and commercializing...inancial results for the fiscal year ended Septemb... $58.4 million in cash, cash equivalents and short...9 Highlights ,, RG7128 ,, Phase 2b Tria...
(Date:11/25/2009)... -- BioTrends Research Group, Inc. released Wave 1...the first in a multi-phase syndicated market resea...Biotech,s Stelara, from product launch through the...he report provides quantitative information from 7...n from a subset of 20. The reports assess trial a...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Reminder 3A Transgenomic Inc Announces Second Quarter 2009 Earnings Release Conference Call Webcast 13529 1Reminder 3A Transgenomic Inc Announces Second Quarter 2009 Earnings Release Conference Call Webcast 13529 2VJ Day marked with launch of POW project on Merseyside 54315 1VJ Day marked with launch of POW project on Merseyside 54315 2Hebrew U researchers shed light on the brain mechanism responsible for processing of speech 9543 1Hebrew U researchers shed light on the brain mechanism responsible for processing of speech 9543 2
... IIa Clinical Trial in Type 2,Diabetes Patients An...all/ - Transition,Therapeutics Inc. ("Transition")...y Phase IIa clinical trial indicating that 4-weeks...1-I.N.T.(TM), showed,sustained reductions in blood...A1C (HbA1c), for 6 months post-treatment. The type...
...-(BUSINESS WIRE)--Jun 28, 2007,- Progenics Pharmac...icals, a division of Wyeth (NYSE: WYE), today anno...el extension study of,subcutaneous methylnaltrexon... (OIC) in patients with advanced illness. The resu...onal Association of,Supportive Care in Cancer (MAS...
Other Medicine Technology:A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 2Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 3Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 4Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 5Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 6
(Date:11/29/2009)...treatment equals a $41,000 pay raise, researchers ...s) -- Psychological therapy may be much more effec...r winning a lottery prize, suggests an English stu... people who provided information about their menta...ess from a $1,329 course of therapy was so signifi...
(Date:11/29/2009)...nal healthcare,s uncertain future and rising costs...are. Affordable Acupuncture Scottsdale answers the... 29, 2009 -- Affordable Acupuncture, LLC opened in...en met with enthusiasm and gratitude. Its increasi...to two things, need and cost. "As far as I&r...
(Date:11/28/2009)...to consider change after 30-minute psychosocial in... 27 (HealthDay News) -- A program that gets persis...p their dangerous behavior may lead to significant... , The new study included 184 men and women wit...who were randomly assigned to one of two intervent...
(Date:11/27/2009)...27 GSI Group Inc. (Pink ...sion technology products and semiconductor systems...mpany,s shareholders has been scheduled for Friday...eting will be announced in due course. As previou...notice from Stephen Bershad, a holder of greater t...
(Date:11/27/2009)...swire-USNewswire/ -- Considered a highly risky and..., solid organ transplantation is now a life-saving...men and women who gathered at the Winspear Opera H...rom medical centers around the world to celebrate ... Institute (BRTI), one of the pioneers of solid or...
Breaking Medicine News(10 mins):Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3
... an associate professor of medicine at Boston Univ...an in the General Internal Medicine Department at ...director of the Substance Abuse Prevention and Tre...esented at the American Association for the Treatm...
...f of patients, study found , TUESDAY, Oct. 30 (Hea...ib shows promise for treating people with what,s k...er -- a group of patients who typically have a poo... and 3. , As reported in the November issue of T...
...bariatric surgeries to high-volume centers disprop...red patients, populations which are among the most...rn Medical Center researchers shows. , Government...d because some studies have identified better outc...
...E: STE ) today announced financial results for it...007. Fiscal 2008 second quarter revenues,increased... in the second,quarter of fiscal 2007, primarily d...d with net income of $16.4 million, or $0.25 per,d...
...daq(R) Technologies Inc.,(TSX: NDQ), a developer o...ed,therapies for the operating room, will host a c...ancial results for the third quarter ended Septemb...lay: 416-640-1917 or 1-877-289-8525 (Available ...
...ink Sheets: HRAL) announced that it has received a...owned subsidiary of Wal-Mart International, Inc.,(...g-aid clinics in two,Toronto area Wal-Mart Stores.... will both officially open today. This,expansion i...
Other Medicine News:Health News:New Drug Promising Against Tough-to-Treat Kidney Cancer 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 3Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 10Health News:Novadaq announces third quarter 2007 conference call and webcast 2Health News:Novadaq announces third quarter 2007 conference call and webcast 3Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 2Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 3
VS-1/IS-1 Plug
Universal Adaptor Sleeve
Silicone - End Caps
...biatrial stimulation. This is the first implant fo...s. The patients benefit from a lasting improvement...ainst cardiac remodeling. Tupos LA uses biatrial s...ptomatic and medicine resistant atrial tachycardia...
Medicine Products: